How can pharmaceutical firms shore up their sustainability credentials at a time when the entire research landscape is turning on its head? A recent webinar from supply chain leaders World Courier and ...

India’s Contract Research, Development, and Manufacturing Organization (CRDMO) industry is on a strong growth trajectory, ...

Macquarie said that the sector is currently at a turning point, driven by increased pharmaceutical outsourcing due to drug ...

There are many challenges in the pharmaceutical supply chain, from maintaining quality to security issues. Can blockchain provide the end-to-end visibility needed? It’s a good time for the ...

As new tariffs on pharmaceutical products and components loom under the Trump administration's proposed trade policies. Frontier Scientific Solutions, a temperature-controlled storage and ...

With U.S. President Donald Trump’s tariffs targeting imported pharmaceuticals, headaches lie ahead for both American patients ...

There may be scope for an agreement on drug exports to the US though in the other key area in dispute - regulation of digital ...

With the Trump administration announcing plans to impose 25% tariffs on pharmaceuticals, it reignites a critical discussion ...

Pharma needs to utilise the latest technology to maintain agility, and hence competitiveness, across the supply chain, says Patrick Lemoine. The pharmaceutical industry has been one of the best ...

US aid freeze affects HIV and malaria supply chains, FDA postpones rare disease events, and a leap in Texas measles cases. Meanwhile, Mirum Pharma's drug gets FDA approval, Eli Lilly invests in a ...

The news adds to the uncertainty for automakers, which are already bracing for steel, aluminum and country-specific tariffs.

Macquarie suggested a target price of Rs 7,400 for Divis Labs, Rs 1,500 for Suven Pharma, Rs 835 for Syngene and Rs 1,000 for ...